Literature DB >> 34285119

Pima Indian Contributions to Our Understanding of Diabetic Kidney Disease.

Robert G Nelson1, William C Knowler2, Matthias Kretzler3, Kevin V Lemley4, Helen C Looker2, Michael Mauer5, William E Mitch6, Behzad Najafian7, Peter H Bennett2.   

Abstract

Prospective studies in informative populations are crucial to increasing our knowledge of disease. In this perspective, we describe a half century of studies in an American Indian population that transformed our understanding of kidney disease in type 2 diabetes, now recognized as the leading cause of kidney failure worldwide. Serial examinations conducted for many years that included the collection of data and samples across multiple domains captured an unprecedented volume of clinical, physiologic, morphometric, genomic, and transcriptomic data. This work permitted us to extensively characterize the course and determinants of diabetic kidney disease, its pathophysiologic underpinnings, and important secular trends of urgent concern to populations worldwide, including the emergence of youth-onset type 2 diabetes and its effect on development of diabetic kidney disease in midlife. By combining these data using the tools of integrative biology, we are developing new mechanistic insights into the development and progression of diabetic kidney disease in type 2 diabetes. These insights have already contributed to the identification and successful therapeutic targeting of a novel pathway in DKD. We anticipate that this work will continue to expand our understanding of this complex disease and influence its management in the coming years.
© 2021 by the American Diabetes Association.

Entities:  

Mesh:

Year:  2021        PMID: 34285119      PMCID: PMC8385607          DOI: 10.2337/dbi20-0043

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.337


  88 in total

Review 1.  Diabetic nephropathy in type II diabetes.

Authors:  E Ritz; A Stefanski
Journal:  Am J Kidney Dis       Date:  1996-02       Impact factor: 8.860

Review 2.  Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis.

Authors:  W C Knowler; D J Pettitt; M F Saad; P H Bennett
Journal:  Diabetes Metab Rev       Date:  1990-02

3.  Parental hypertension and proteinuria in Pima Indians with NIDDM.

Authors:  R G Nelson; D J Pettitt; M P de Courten; R L Hanson; W C Knowler; P H Bennett
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

4.  Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  D J Pettitt; M F Saad; P H Bennett; R G Nelson; W C Knowler
Journal:  Diabetologia       Date:  1990-07       Impact factor: 10.122

5.  Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria.

Authors:  T W Meyer; P H Bennett; R G Nelson
Journal:  Diabetologia       Date:  1999-11       Impact factor: 10.122

6.  Albuminuria in type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians.

Authors:  R G Nelson; C L Kunzelman; D J Pettitt; M F Saad; P H Bennett; W C Knowler
Journal:  Diabetologia       Date:  1989-12       Impact factor: 10.122

7.  Size- and charge selectivity of glomerular filtration in Type 1 (insulin-dependent) diabetic patients with and without albuminuria.

Authors:  T Deckert; A Kofoed-Enevoldsen; P Vidal; K Nørgaard; H B Andreasen; B Feldt-Rasmussen
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

8.  High prevalence of diabetes in young Pima Indians: evidence of phenotypic variation in a genetically isolated population.

Authors:  P J Savage; P H Bennett; R G Senter; M Miller
Journal:  Diabetes       Date:  1979-10       Impact factor: 9.461

9.  Determinants of end-stage renal disease in Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus and proteinuria.

Authors:  R G Nelson; W C Knowler; D R McCance; M L Sievers; D J Pettitt; M A Charles; R L Hanson; Q Z Liu; P H Bennett
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

10.  JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial.

Authors:  Katherine R Tuttle; Frank C Brosius; Sharon G Adler; Matthias Kretzler; Ravindra L Mehta; James A Tumlin; Yoshiya Tanaka; Masakazu Haneda; Jiajun Liu; Maria E Silk; Tracy E Cardillo; Kevin L Duffin; Joseph V Haas; William L Macias; Fabio P Nunes; Jonathan M Janes
Journal:  Nephrol Dial Transplant       Date:  2018-11-01       Impact factor: 5.992

View more
  3 in total

1.  Structural Lesions on Kidney Biopsy in Youth-Onset and Adult-Onset Type 2 Diabetes.

Authors:  Helen C Looker; Laura Pyle; Tim Vigers; Cameron Severn; Pierre J Saulnier; Behzad Najafian; Michael Mauer; Robert G Nelson; Petter Bjornstad
Journal:  Diabetes Care       Date:  2022-02-01       Impact factor: 19.112

Review 2.  Cellular and molecular interrogation of kidney biopsy specimens.

Authors:  Michael T Eadon; Pierre C Dagher; Tarek M El-Achkar
Journal:  Curr Opin Nephrol Hypertens       Date:  2022-03-01       Impact factor: 2.894

3.  Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes.

Authors:  Farsad Afshinnia; Evan L Reynolds; Thekkelnaycke M Rajendiran; Tanu Soni; Jaeman Byun; Masha G Savelieff; Helen C Looker; Robert G Nelson; George Michailidis; Brian C Callaghan; Subramaniam Pennathur; Eva L Feldman
Journal:  Ann Clin Transl Neurol       Date:  2022-08-03       Impact factor: 5.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.